(Q33373390)

26 July 2017

1 reference

title

Rabbit antithymocyte globulin induction therapy in adult renal transplantation (English)

1 reference

26 July 2017

Karen L Hardinger

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

26 July 2017

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

12

1 reference

26 July 2017

page(s)

1771-1783

1 reference

Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Tolerogenic immunosuppression for organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Delayed graft function in renal transplantation: etiology, management and long-term significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1771

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.12.1771

1 reference

26 July 2017

1 reference